What if you invested $1,000 in Novo Nordisk in 2020? (Inflation-Adjusted)
NVO · Healthcare · Adjusted to 2026 dollars using BLS CPI-U data
View nominal (non-adjusted) versionA $1,000 investment in Novo Nordisk in 2020 grew to $1,377 in nominal terms. But 2020 dollars had 25% more purchasing power than today. After adjusting for cumulative inflation using BLS CPI-U data, the real value of that growth works out to $1,102 in constant 2020 dollars, equivalent to a +1.6% real annualized return.
Nominal final value
$1,377
+37.7% total return
Real value (2020 dollars)
$1,102
+10.2% real total return
Real annualized return
+1.6%
vs. +5.3% nominal annualized
Year-by-Year (Inflation-Adjusted)
$1,000 in Novo Nordisk since 2020, values in constant 2020 dollars
| Year | Nominal Value | Real Value (2020 $) |
|---|---|---|
| 2020 | $1,000 | $1,000 |
| 2021 | $1,169 | $1,113 |
| 2022 | $1,711 | $1,492 |
| 2023 | $2,414 | $2,027 |
| 2024 | $4,042 | $3,298 |
| 2025 | $3,008 | $2,406 |
| 2026 | $2,175 | $1,740 |
Inflation adjustment uses BLS CPI-U annual data, deflated to 2026 dollars. Nominal stock data from Yahoo Finance (split-adjusted closing prices). Real values are expressed in constant 2020 purchasing-power dollars. For informational and educational purposes only. Not financial advice. Past performance does not guarantee future results. See our methodology and full disclaimer.